National Resilience Lays Off 120 Employees at Former Bluebird Bio Gene Therapy Facility in Durham, North Carolina

Layoffs:
National Resilience is laying off 120 employees at its Durham, North Carolina, gene therapy facility, which was acquired from Bluebird Bio in 2021 for $110 million135.

Reason:
The layoffs are part of the company's effort to "right-size" the facility based on demand in the gene therapy sector, indicating a need to reduce headcount in some areas while growing in others35.

Timeline:
The layoffs will begin on March 7, 2025, with some employees remaining until December 15, 2025, to assist with certain tasks5.

Broader Context:
This move follows similar layoffs at National Resilience's Alachua, Florida, site, where 105 employees were let go, and is part of a broader trend of job cuts in the biotech industry due to harsh macroeconomic conditions15.

Company Background:
National Resilience, a CDMO, has been expanding its operations and capabilities across North America, including a $225 million investment in its Cincinnati facility to increase drug product capacity15.

Sources:

1. https://www.manufacturingdive.com/news/biotech-national-resilience-120-layoffs-durham-north-carolina/736819/

3. https://endpts.com/resilience-cuts-120-employees-at-a-former-bluebird-gene-therapy-site/

5. https://www.pharmamanufacturing.com/industry-news/news/55259750/national-resilience-to-lay-off-120-employees-at-north-carolina-gene-therapy-site